By Chris Bailey of Financial Orbit | Thursday 4 March 2021
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
An excitable day today as I had my first Covid-19 vaccine (thanks for all those involved including a stock I have not held for years, AstraZeneca (AZN)) and the further progress at Aviva (AV) was very pleasing. As I noted about the latter here, a couple of weeks ago, its simplification process remains strong. For what it is worth, my own target price has risen up by a few more pence above four quid and there is even a 5% plus dividend yield on offer. The shares are still a strong hold for me.